Structural principles that govern the peptide-binding motifs of class I MHC molecules

Journal of Molecular Biology

Volumn 281, Issue 5, 1998, Pages 929-947

  Zhang, Chao ^a   Anderson, Abraham ^a   DeLisi, Charles ^a  

^a Boston University   (United States)

Author keywords

Anchor residues; Molecular recognition; Peptide binding specificity; Polymorphism; Structural pockets

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AMINO ACID SEQUENCE; ARTICLE; DNA POLYMORPHISM; EVOLUTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

EID: 0032483463     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.1982     Document Type: Article

References (60)

1. 2-microglobulin and peptide. Proc. Natl Acad. Sci. USA. 94:1997;6880-6885
2. Bjorkman P.J., Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59:1990;253-288
3. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature. 329:1987;512-518
4. Bodmer J.G., Marsh S.G.E., Albert E.D., Bodmer W.F., Bontrop R.E., Charron D., Dupont B., Erlich H.A., Fauchet R., Mach B., Mayr W.R., Parham P., Sasazuki T., Schreuder G.M.T., Strominger J.L., Svejgaard A., Terasaki P.I. Nomenclature for factors of the HLA system, 1996. Tissue Antigens. 49:1997;297-321
5. Boon T., Cerottini J.C., van den Eynde B., van der Bruggen P., van Pel A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:1994;337-365
6. Bouvier M., Wiley D.C. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science. 265:1994;398-402
7. Brusic V., Rudy G., Kyne A., Harrison L. MHCPEP, a database of MHC-binding peptides-update 1996. Nucl. Acids Res. 25:1997;269-272. (http://wehih.wehi.edu.au/mhcpep/).
8. Christinck E.R., Luscher M.A., Barber B.H., Williams D.B. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature. 352:1991;67-70
9. Collins E.J., Garboczi D.N., Karpusas M.N., Wiley D.D. The three-dimensional structure of a class I major histocompatibility complex molecule missing the α3 domain of the heavy chain. Proc. Natl Acad. Sci. USA. 92:1995;1218-1221
10. Collins E.J., Garboczi D.N., Wiley D.C. Three dimensional structure of a peptide extending out one end of a class I MHC binding site. Nature. 371:1994;626-629
11. d sequence motif, quantitative binding, and molecular modeling of the complex. J. Exp. Med. 176:1992;1681-1692
12. Coulie P.G. Human tumor antigens recognized by cytolytic T lymphocytes. Dalgleish A.G., Browning M.J. Tumor Immunology: Immunotherapy and Cancer Vaccines. 1996;95-125 Cambridge University Press, Cambridge
13. del Guercio M.F., Sidney J., Hermanson G., Perez C., Grey H.M., Kubo R.T., Sette A. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:1995;685-693
14. Eisen H.N., Sykulev Y., Tsomides T.J. Antigen-specific T-cell receptors and their reactions with complexes formed by peptides with major histocompatibility complex proteins. Advan. Protein Chem. 49:1996;1-56
15. Falk K., Rotzschke O. Consensus motifs and peptide ligands of MHC class I molecules. Sem. Immunol. 5:1993;81-94
16. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H.-G. Allele-specific motifs revealed by sequencing of selfpeptides eluted form MHC molecules. Nature. 351:1991;290-296
17. b. Science. 257:1992;919-927
18. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl Acad. Sci. USA. 92:1995;2479-2483
19. Garrett T.P.J., Saper M.A., Bjorkman P.J., Strominger J.L., Wiley D.C. Specificity pockets for the side chains of peptide antigen in HLA-Aw68. Nature. 342:1989;692-696
20. Gaur A., Fathman C.G. Immunotherapeutic strategies directed at the trimolecular complex. Advan. Immunol. 56:1994;219-265
21. Germain R. MHC-dependent antigen processing and peptide presentation providing ligands for T lymphocyte. Cell. 76:1994;287-299
22. Guo H.-C., Jardetzky T.S., Garrett T.P., Lane W.S., Strominger J.L., Wiley D.C. Different length peptides bind to HLA-Aw68 at their ends but bulge out in the middle. Nature. 360:1992;364-366
23. Guo H.-C., Madden D.R., Silver M.L., Jardtzky T.S., Gorga J.C., Strominger J.L., Wiley D.C. Comparison of the P2 specificity pocket in three human histocompatibility antigens, HLA-A*6801, HLA-A*0201, and HLA-B*2705. Proc. Natl Acad. Sci. USA. 90:1993;8053-8057
24. Heemels M.T., Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:1995;463-491
25. Hunt D.F., Henderson R.A., Shabanowitz J., Sakaguchi K., Michel H., Sevilir N., Cox A.L., Appella E., Engelhard V.H. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science. 255:1992;1261-1263
26. Imanishi T., Akaza T., Kimura A., Tokunaga K., Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. Tsuji K., Aizawa M., Sasazuki T. HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference. vol. 1:1992;1065-1220 Oxford University Press, Oxford. chapt. W15.1.
27. Jackson M.R., Peterson P.A. Assembly and intracellular transport of MHC class I molecules. Annu. Rev. Cell. Biol. 9:1993;207-235
28. Jardetzky T.S., Lane W.S., Robinson R.A., Madden D.R., Wiley D.C. Identification of self peptides bound to purified HLA-B27. Nature. 353:1991;326-329
29. Kabat E.A., Wu T.T., Perry H.M., Gottesman K.S., Foeller C. Sequences of Proteins of Immunological Interest. 5th edit :1991;U.S. Department of Health and Human Services, Bethesda, MD
30. Khilko S.N., Corr M., Boyd L.F., Lees A., Inman J.K., Margulies D.H. Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity. J. Biol. Chem. 268:1993;15425-15434
31. Korber B., Brander C., Moore J., D'Souza P., Walker B., Koup R., Haynes B., Myers G. Editors of HIV Molecular Immunology Database 1996. 1996;Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, NM. (http://hivweb.lanl.gov/immuno/)
32. Madden D.R. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:1995;587-622
33. Madden D.R., Garboczi D.N., Wiley D.C. The antigenic identity of peptide-MHC complexes a comparison of the conformations of five viral peptides presented by HLA-A2. Cell. 75:1993;693-708
34. Madden D.R., Gorga J.C., Strominger J.L., Wiley D.C. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 70:1992;1035-1048
35. Matsumura M., Fremont D.H., Peterson P.A., Wilson I.A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science. 257:1992;927-934
36. Nicholls A., Sharp K., Honig B. Protein folding and association, insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11:1991;282-290
37. Nossal G.J.V. Negative selection of lymphocytes. Cell. 76:1994;229-239
38. Parham P., Lomen C.E., Lawlor D.A., Ways J.P., Holmes N., Coppin H.L., Salter R.D., Wan A.M., Ennis P.D. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc. Natl Acad. Sci. USA. 85:1988;4005-4009
39. 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound. J. Immunol. 149:1992;1896-1904
40. Parker K.C., Biddison W.E., Coligan J.E. Pocket mutations of HLA-B27 show that anchor residues act cumulatively to stabilize peptide binding. Biochemistry. 33:1994;7736-7743
41. Rammensee H.-G., Friede T., Stevanovic S. MHC ligands and peptide motifs first listing. Immunogenetics. 41:1995;178-228
42. Reid S.W., Mcadam S., Smith K.J., Klenerman P., O'Callaghan C.A., Harlos K., Jakobsen B.K., McMichael A.J., Bell J.I., Stuart D., Jones E.Y. Antagonist HIV-1 gag peptides induce structural changes in HLA-B8. J. Exp. Med. 184:1996;2279-2286
43. Saito Y., Peterson P.A., Matsumura M. Quantitation of peptide anchor residue contributions to class I major histocompatibility complex molecule binding. J Biol. Chem. 268:1993;21309-21317
44. Sanner M.F., Olson A.J., Spehner J.-C. Reduced surface an efficient way to compute molecular surfaces. Biopolymers. 38:1996;305-320
45. Saper M.A., Bjorkman P.J., Wiley D.C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219:1991;277-319
46. Sette A., Sidney J., del Guercio M.-F., Southwood S., Ruppert J., Dahlberg C., Grey H.M., Kubo R. Peptide binding to the most frequent HLA-A class I alleles measured by quantitiative molecule binding assay. Mol. Immunol. 31:1994;813-822
47. Sidney J., del Guercio M.-F., Southwood S., Engelhard V.H., Appella E., Rammensee H.-G., Falk K., Rotzshke O., Takiguchi M., Kubo R.T., Grey H.M., Sette A. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:1995;247-259
48. Sidney J., Grey H.M., Southwood S., Celis E., Wentworth P.A., del Guercio M.F., Kubo R.T., Chesnut R.W., Sette A. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum. Immunol. 45:1996;79-93
49. Silver M.L., Guo H.-C., Strominger J.L., Wiley D.C. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature. 360:1992;367-369
50. Smith K.J., Reid S.W., Stuart D.I., McMichael A.J., Jones E.Y., Bell J.I. An altered position of the α2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity. 4:1996;203-213
51. Smith K.J., Reid S.W., Harlos K., McMichael A.J., Stuart D.I., Bell J.I., Jones E.Y. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity. 4:1996;215-228
52. Stauss H.J., Dahl A.M. Cellular oncogenes for tumour immunity immunotherapy. Dalgleish A.G., Browning M.J. Tumor Immunology: Immunotherapy and Cancer Vaccines. 1996;153-184 Cambridge University Press, Cambridge
53. Townsend A., Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:1989;601-624
54. van der Bruggen P., Bastin J., Gajewski T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Euro. J. Immunol. 24:1994;3038-3043
55. Vasmatzis G., Zhang C., Cornette J.L., DeLisi C. Computational determination of side chain specificity of pockets in class I MHC molecules. Mol. Immunol. 33:1996;1231-1239
56. Yewdell J.W., Bennink J.R. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Advan. Immunol. 52:1992;1-123
57. bat 2.4 Å resolution implications for antigen-determinant selection. Cell. 76:1994;39-50
58. Zhang C., Cornette J.L., Berzofsky J.A., DeLisi C. The organization of human leukocyte antigen class I epitopes in HIV genome products implications for HIV evolution and vaccine design. Vaccine. 15:1997;1291-1302
59. bmolecule containing a single viral peptide implications for peptide binding and T-cell receptor recognition. Proc. Natl Acad. Sci. USA. 89:1992;8403-8407
60. Zinkernagel R.M., Doherty P.C. MHC restricted cytotoxic T cells studies on the biological role of polymorphic major transplantation antigens in determining T cell restriction specificity, function and responsiveness. Advan. Immunol. 27:1979;51-177